“… 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 Evidence-based clinical management by an ID specialist allows for early source control, which is associated with reduced complications and recurrence 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 and potentially lower health care expenditures. Given the current emphasis among clinical decision-makers on high-value affordable care 18 , 19 , 20 that aims to optimize allocation of resources while improving patient outcomes, the aim of this study was to perform a cost-effectiveness analysis comparing use of ID consultation with no ID consultation for the management of SAB.…”